Archive for Tag: Pfizer COVID

Pfizer Inc

Pfizer vaccine for children under 5 may be available in U.S. by end-Feb

Pfizer Inc (NYSE: PFE) is trading down 3.02% at 52.69 Pfizer Inc (NYSE: PFE) and Germany’s BioNTech SE (NASDAQ: BNTX) are expected to submit an emergency use authorization request as early as Tuesday to the U.S. Food and Drug Administration (FDA) for vaccines for children aged six months to 5...

Read More

Pfizer files for U.S. authorization of promising COVID-19 antiviral pill

Pfizer Inc (NYSE:PFE) is trading down 0.10% at 49.60 Pfizer Inc (NYSE:PFE)said on Tuesday it is seeking U.S. authorization of its experimental antiviral COVID-19 pill that cut the chance of hospitalization or death for adults at risk of severe disease by 89% in a clinical trial. Pfizer said it...

Read More

Pfizer submits data for COVID-19 vaccine in younger children

Pfizer Inc is trading down 0.84% at 43.57 Pfizer Inc and BioNTech SE (NASDAQ:BNTX) on Tuesday submitted initial trial data for their COVID-19 vaccine in children aged 5 to 11 and said they would make a formal request with U.S. regulators for emergency use in the coming weeks. Coronavirus...

Read More

TOP 5 STOCKS TO WATCHOUT & TRADE TODAY – SEPTEMBER 23, 2021

1.VOLKSWAGEN: Software Volkswagen AG used to alter pollutant emissions based on the outside temperature and altitude is illegal and cannot be justified by its role in protecting the engine, an adviser to the EU’s top court said on Thursday. The finding, if confirmed by the Court of Justice of...

Read More

Pfizer on track for U.S. vaccine boosters, Moderna lagging, Fauci says

Pfizer (NYSE:PFE) is trading flat at 46.84 Top U.S. infectious disease expert Rd. Anthony Fauci said on Sunday that officials were likely to soon get the regulatory go-ahead to administer COVID-19 vaccine booster shots made byPfizer(NYSE:PFE), althoughModerna(NASDAQ:MRNA) booster could take a little longer. Asked on CBS’ “Face the Nation,”...

Read More

Pfizer seeks U.S. approval for COVID vaccine booster

Pfizer (NYSE:PFE)is trading up 0.24% at 47.50 Pfizer Inc on Wednesday said a booster dose of its two-shot COVID-19 vaccine spurs a more than threefold increase in antibodies against the coronavirus, as the company seeks U.S. regulatory approval for a third injection. The drugmaker and its German partner BioNTech...

Read More

Top 5 Stocks To Watchout & Trade Today – July 09, 2021

1. PFIZER:Pfizer Inc plans to ask U.S. regulators to authorize a booster dose of its COVID-19 vaccine within the next month, the drugmaker’s top scientist said on Thursday, based on evidence of greater risk of reinfection six months after inoculation and the spread of the highly contagious Delta variant....

Read More

UK competition regulator looking into $39 billion AstraZeneca-Alexion deal

AstraZeneca (NASDAQ:AZN) is trading down 0.26% at 8129.00 Britain’s competition regulator is reviewing AstraZeneca (NASDAQ:AZN)’s $39 billion buyout of U.S.-based Alexion (NASDAQ:ALXN) on concerns it could reduce competition in the UK market or elsewhere. The UK’s Competition and Markets Authority (CMA) said on Tuesday it was inviting comments from...

Read More